CTI BioPharma Corp - Company Profile
Powered by
All the data and insights you need on CTI BioPharma Corp in one report.
- Save hours of research time and resources with
our up-to-date CTI BioPharma Corp Strategy Report
- Understand CTI BioPharma Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
CTI BioPharma Corp (CTI BioPharma), a subsidiary of Swedish Orphan Biovitrum AB, focuses on the acquisition, development and commercialization of novel therapies for the treatment of a wide range of blood-related cancers. The company sole product candidate in active development stage is evaluated for the treatment of myelofibrosis for adult patients.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer